Insiders Alvotech Nyse

Equities

ALVO

LU2458332611

Market Closed - Nyse Other stock markets 01:30:00 16/05/2024 am IST			5-day change	1st Jan Change
13.35 ^USD	0.00%		-1.40%	+42.32%

30/04	Alvotech to Manufacture Humira Biosimilar for Quallent Pharmaceuticals	MT
30/04	Alvotech to Make Humira Biosimilar Adalimumab-ryvk for Quallent	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Alvotech Announces Executive Changes	01/03	CI
Alvotech Names Faysal Kalmoua as COO	05/23/05	MT
Alvotech Names New COO	05/23/05	MT
Alvotech Announces Changes to the Leadership Team	05/23/05	CI
Debt Ceiling Deal in Focus Amid Rising Exchange-Traded Funds, Equity Futures Pre-Bell Friday	19/23/19	MT
Biosimilar Maker Alvotech Names New Chief Quality Officer	20/23/20	MT
Sarah Tanksley Joins Board of Directors for Alvotech hf. and Sandra Casaca Appointed Chief Quality Officer	20/23/20	GL
Sarah Tanksley Joins Board of Directors for Alvotech hf. and Sandra Casaca Appointed Chief Quality Officer	20/23/20	AQ
Alvotech Appoints Sandra Casaca as Chief Quality Officer	20/23/20	CI
Alvotech Chief Executive to Leave; Executive Chairman Named CEO	02/22/02	MT
Alvotech Appoints Hafrun Fridriksdottir as Chief Operating Officer, Effective January 1, 2023	02/22/02	CI
Alvotech Announces Executive Changes, Effective January 1, 2023	02/22/02	CI
Alvotech Names New Chief Quality Officer	12/22/12	MT
Alvotech Announces Executive Changes	12/22/12	CI
Alvotech Expands its Board of Directors as Part of Transition from Private to Publicly Traded Company	14/22/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW